 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
10/6/20‡ Amag Pharmaceuticals, Inc. 8-K:7,8,9 10/5/20 13:744K
8/17/20 Amag Pharmaceuticals, Inc. 8-K:8 8/17/20 12:514K
10/8/19 Amag Pharmaceuticals, Inc. 8-K:1,5,8,9 10/8/19 12:397K EdgarAgents LLC/FA
9/12/19 Amag Pharmaceuticals, Inc. 8-K:8,9 9/12/19 11:263K EdgarAgents LLC/FA
6/24/19‡ Amag Pharmaceuticals, Inc. 8-K:7,8,9 6/21/19 2:263K
2/5/18 Amag Pharmaceuticals, Inc. 8-K:8,9 2/5/18 2:50K
5/8/17 Amag Pharmaceuticals, Inc. 8-K:1,8,9 5/3/17 5:379K Toppan Merrill/FA
5/3/17 Amag Pharmaceuticals, Inc. 8-K:8,9 5/3/17 2:72K Toppan Merrill/FA
1/9/17 Amag Pharmaceuticals, Inc. 8-K:1,2,7,8 1/8/17 4:5.8M Toppan Merrill/FA
7/22/16‡ Amag Pharmaceuticals, Inc. 8-K:8 7/19/16 1:19K Toppan Merrill/FA
2/8/16 Amag Pharmaceuticals, Inc. 8-K:8 2/5/16 1:23K Toppan Merrill/FA
12/17/15 Amag Pharmaceuticals, Inc. 8-K:5,8,9 12/15/15 2:128K Toppan Merrill/FA
8/12/15 Amag Pharmaceuticals, Inc. 8-K:8,9 8/12/15 2:40K Toppan Merrill/FA
8/6/15 Amag Pharmaceuticals, Inc. 8-K:8,9 8/5/15 2:51K Toppan Merrill/FA
7/31/15 Amag Pharmaceuticals, Inc. 8-K:1,8,9 7/29/15 5:596K Toppan Merrill/FA
7/29/15 Amag Pharmaceuticals, Inc. 8-K:8,9 7/29/15 8:3.2M Toppan Merrill/FA
5/28/15 Amag Pharmaceuticals, Inc. 8-K:5,8,9 5/21/15 2:105K Toppan Merrill/FA
3/18/15 Amag Pharmaceuticals, Inc. 8-K:8 3/18/15 1:29K Toppan Merrill/FA
2/26/15 Amag Pharmaceuticals, Inc. 8-K:1,8,9 2/23/15 5:614K Toppan Merrill/FA
2/10/15 Amag Pharmaceuticals, Inc. 8-K:8,9 2/10/15 2:270K Toppan Merrill/FA
| ____________ | | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | | ¹ | Filing/Form Type: | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. |
|
